Literature DB >> 17492945

The dopaminergic system in hypertension.

Chunyu Zeng1, Meng Zhang, Laureano D Asico, Gilbert M Eisner, Pedro A Jose.   

Abstract

Dopamine plays an important role in the pathogenesis of hypertension by regulating epithelial sodium transport, vascular smooth muscle contractility and production of reactive oxygen species and by interacting with the renin-angiotensin and sympathetic nervous systems. Dopamine receptors are classified into D(1)-like (D(1) and D(5)) and D(2)-like (D(2), D(3) and D(4)) subtypes based on their structure and pharmacology. Each of the dopamine receptor subtypes participates in the regulation of blood pressure by mechanisms specific for the subtype. Some receptors regulate blood pressure by influencing the central and/or peripheral nervous system; others influence epithelial transport and regulate the secretion and receptors of several humoral agents. This review summarizes the physiology of the different dopamine receptors in the regulation of blood pressure, and the relationship between dopamine receptor subtypes and hypertension.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17492945     DOI: 10.1042/CS20070018

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  40 in total

Review 1.  Potential dopamine-1 receptor stimulation in hypertension management.

Authors:  Mohammad Asghar; Seyed K Tayebati; Mustafa F Lokhandwala; Tahir Hussain
Journal:  Curr Hypertens Rep       Date:  2011-08       Impact factor: 5.369

2.  Dopamine stabilizes tumor blood vessels by up-regulating angiopoietin 1 expression in pericytes and Kruppel-like factor-2 expression in tumor endothelial cells.

Authors:  Debanjan Chakroborty; Chandrani Sarkar; Hongmei Yu; Jiang Wang; Zhongfa Liu; Partha Sarathi Dasgupta; Sujit Basu
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-05       Impact factor: 11.205

Review 3.  Proximal nephron.

Authors:  Jia L Zhuo; Xiao C Li
Journal:  Compr Physiol       Date:  2013-07       Impact factor: 9.090

Review 4.  Use of inotropes and vasopressor agents in critically ill patients.

Authors:  Mansoor N Bangash; Ming-Li Kong; Rupert M Pearse
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

5.  Age-related hypertension and salt sensitivity are associated with unique cortico-medullary distribution of D1R, AT1R, and NADPH-oxidase in FBN rats.

Authors:  Indira Pokkunuri; Gaurav Chugh; Imran Rizvi; Mohammad Asghar
Journal:  Clin Exp Hypertens       Date:  2015-01-06       Impact factor: 1.749

6.  Newly Developed Dopamine D3 Receptor Antagonists, R-VK4-40 and R-VK4-116, Do Not Potentiate Cardiovascular Effects of Cocaine or Oxycodone in Rats.

Authors:  Chloe J Jordan; Bree A Humburg; Eric B Thorndike; Anver Basha Shaik; Zheng-Xiong Xi; Michael H Baumann; Amy Hauck Newman; Charles W Schindler
Journal:  J Pharmacol Exp Ther       Date:  2019-09-27       Impact factor: 4.030

7.  Renal proximal tubule Na,K-ATPase is controlled by CREB-regulated transcriptional coactivators as well as salt-inducible kinase 1.

Authors:  Mary Taub; Sudha Garimella; Dongwook Kim; Trivikram Rajkhowa; Facundo Cutuli
Journal:  Cell Signal       Date:  2015-10-09       Impact factor: 4.315

8.  Brain angiotensin and dopaminergic degeneration: relevance to Parkinson's disease.

Authors:  Jose L Labandeira-Garcia; Jannette Rodriguez-Pallares; Ana I Rodríguez-Perez; Pablo Garrido-Gil; Begoña Villar-Cheda; Rita Valenzuela; Maria J Guerra
Journal:  Am J Neurodegener Dis       Date:  2012-11-18

9.  Predominant role of the dopamine D3 receptor subtype for mediating the quinpirole-induced inhibition of the vasopressor sympathetic outflow in pithed rats.

Authors:  Inna Ruiz-Salinas; Abimael González-Hernández; Guadalupe Manrique-Maldonado; Bruno A Marichal-Cancino; Alain H Altamirano-Espinoza; Carlos M Villalón
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-02-19       Impact factor: 3.000

10.  Podocyte-specific expression of organic cation transporter PMAT: implication in puromycin aminonucleoside nephrotoxicity.

Authors:  Li Xia; Mingyan Zhou; Thomas F Kalhorn; Horace T B Ho; Joanne Wang
Journal:  Am J Physiol Renal Physiol       Date:  2009-04-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.